Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors-Reference-Cited by-同舟云学术

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

Published:2021-03-24 Issue:18 Volume:60 Page:10423-10429
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Breidenbach Julian¹^ORCID,Lemke Carina¹^ORCID,Pillaiyar Thanigaimalai¹²^ORCID,Schäkel Laura¹^ORCID,Al Hamwi Ghazl¹^ORCID,Diett Miriam¹,Gedschold Robin¹,Geiger Nina³^ORCID,Lopez Vittoria¹^ORCID,Mirza Salahuddin¹^ORCID,Namasivayam Vigneshwaran¹^ORCID,Schiedel Anke C.¹^ORCID,Sylvester Katharina¹,Thimm Dominik¹^ORCID,Vielmuth Christin¹,Phuong Vu Lan¹,Zyulina Maria¹,Bodem Jochen³^ORCID,Gütschow Michael¹^ORCID,Müller Christa E.¹^ORCID

Affiliation:

1. Pharmaceutical Institute Pharmaceutical & Medicinal Chemistry University of Bonn An der Immenburg 4 53121 Bonn Germany), E-mails

2. Present address: Pharmaceutical Institute Pharmaceutical Chemistry Eberhard-Karls-University Tübingen Auf der Morgenstelle 8 72076 Tübingen Germany

3. Institute for Virology and Immunobiology Julius-Maximilians-University Würzburg Versbacher Strasse 7 97078 Würzburg Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202016961

Reference65 articles.

2. Emerging coronaviruses: Genome structure, replication, and pathogenesis

3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2